How many regulatory decisions are you making “just to be safe”… instead of strategically? Under Regulation (EU) 2017/745, we see it every week: companies launching clinical investigations… when they could actually avoid them.
Read More
Maytal is excited to share an important strategic development in our March 2026 newsletter: we are actively exploring expanded opportunities in regulatory compliance for medical devices and in vitro diagnostics (IVD) across Southeast Asia.
Read More
London, 13–14 March 2026 – Maytal is pleased to announce its participation in ACE 2026 (Aesthetics Conference & Exhibition), the UK’s leading event for medical aesthetics.
Read More
Coventry, 11–12 March 2026 – Maytal is pleased to announce its participation in Medical Technology UK 2026, one of the UK’s premier events dedicated to medical device innovation and manufacturing excellence.
Read More
The publication of EN ISO 10993-1:2025 represents a key milestone for all medical device manufacturers who will be required, during 2026, to assess the need to update their biological evaluation documentation. Maytal can support you in a comprehensive and structured manner to address this regulatory update efficiently and without slowing down your ongoing projects
Read More
As we enter 2026, the post-Brexit regulatory landscape for medical devices continues to evolve, presenting both challenges and opportunities for manufacturers targeting the UK (Great Britain) and EU markets.
Read More
We’re pleased to announce that Maytal will be participating in MEDICA 2025, the world’s leading trade fair for the medical industry, taking place in Düsseldorf, Germany, from November 17–20, 2025.
Read More
London, 25–26 September 2025 – Maytal will attend the CCR Expo 2025 at the Excel London, a premier event for the medical aesthetics community.
Read More